论文部分内容阅读
2015年美国心脏学会(AHA)、美国心脏病学会(ACC)、美国高血压学会(ASH)联合发布了《伴冠心病的高血压患者治疗科学声明》,以通过使用具有明确降低心血管风险适应证的降压药物,优化高血压合并冠心病的降压治疗方案,提升高血压合并冠心病患者的降压治疗的达标率、减少心血管事件的发生和死亡。本文总结翻译声明中的部分要点,以供读者参考。
2015 American Heart Association (AHA), American College of Cardiology (ACC) and American Society of Hypertension (ASH) jointly released the “Scientific Statement on Treatment of Hypertensive Patients with Coronary Heart Disease” to reduce the risk of cardiovascular diseases Card antihypertensive drugs to optimize antihypertensive treatment of hypertension with coronary heart disease treatment programs to enhance the compliance rate of antihypertensive treatment of patients with hypertension and coronary heart disease to reduce the incidence of cardiovascular events and death. This article summarizes some of the key points in the translation statement for readers’ reference.